Chemfab Alka.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE783X01023
  • NSEID: CHEMFAB
  • BSEID: 541269
INR
397.95
-12.85 (-3.13%)
BSENSE

Jan 29

BSE+NSE Vol: 68.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

68.72 k (110.96%) Volume

Shareholding (Dec 2025)

FII

0.08%

Held by 2 FIIs

DII

0.21%

Held by 0 DIIs

Promoter

72.13%

Has Chemfab Alka. declared dividend?

06-Jun-2025

Yes, Chemfab Alkalis Ltd has declared a 12% dividend, amounting to ₹1.2 per share, with an ex-date of September 13, 2024. Despite recent fluctuations, the company has shown strong long-term total returns, particularly over the 3 to 5 year periods.

Chemfab Alkalis Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 1.2<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -31.68%, with a dividend return of 0%, resulting in a total return of -31.68%.<BR><BR>For the 1 year period, the price return was 33.47%, the dividend return was 0.19%, leading to a total return of 33.66%.<BR><BR>Over the 2 years period, the price return was 130.2%, with a dividend return of 0.74%, culminating in a total return of 130.94%.<BR><BR>In the 3 years period, the price return was 354.78%, the dividend return was 2.32%, resulting in a total return of 357.1%.<BR><BR>For the 4 years period, the price return was 413.05%, with a dividend return of 2.46%, leading to a total return of 415.51%.<BR><BR>In the 5 years period, the price return was 440.62%, with a dividend return of 3.57%, resulting in a total return of 444.19%.<BR><BR>Overall, Chemfab Alkalis Ltd has declared a dividend, and while the recent returns show significant fluctuations, the long-term performance indicates a strong upward trend in total returns, particularly over the 3 to 5 year periods.

View full answer

Is Chemfab Alka. overvalued or undervalued?

09-Jun-2025

As of May 23, 2024, Chemfab Alkalis Ltd. is considered very expensive and overvalued, with a PE ratio of 367.03 and significant underperformance against the Sensex, indicating a lack of growth expectations and high valuation compared to industry benchmarks.

As of 23 May 2024, the valuation grade for Chemfab Alkalis Ltd. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued. Key ratios highlight this concern, with a PE ratio of 367.03, an EV to EBIT of 155.27, and a Price to Book Value of 2.85, all of which are substantially higher than typical industry benchmarks.<BR><BR>In comparison to peers, Chemfab Alkalis Ltd. stands out with a PE ratio significantly above the average, while its EV to EBITDA ratio of 26.21 aligns with its high valuation. Notably, the company has a PEG ratio of 0.00, suggesting no growth expectations are priced in, which further emphasizes its overvaluation. Recent performance shows that Chemfab has underperformed against the Sensex, with a year-to-date return of -26.8% compared to the Sensex's 5.56%, reinforcing the notion that the stock may be overvalued in the current market context.

View full answer

Who are the peers of the Chemfab Alka.?

16-Jul-2025

Chemfab Alka.'s peers include J.G.Chemicals, I G Petrochems, and Andhra Sugars, among others. Chemfab Alka. shows excellent growth with a 1-year return of 7.63%, while peers like J.G.Chemicals have higher returns, and Andhra Sugars has the lowest at -30.73%.

Peers: The peers of Chemfab Alka. are J.G.Chemicals, I G Petrochems, Amines & Plast., Sr.Rayala.Hypo, Andhra Sugars, TGV Sraac, Tuticorin Alkali, Transpek Inds., and Indo Borax & Ch.<BR><BR>Quality Snapshot: Excellent management risk is observed at J.G.Chemicals, I G Petrochems, Sr.Rayala.Hypo, Andhra Sugars, and Indo Borax & Ch. while Average management risk is found at Chemfab Alka., TGV Sraac, Tuticorin Alkali, and Amines & Plast. Below Average management risk is noted for Transpek Inds. and Andhra Sugars. In terms of growth, Excellent growth is seen at Chemfab Alka. and the rest have Below Average growth. Capital Structure ratings show Excellent for J.G.Chemicals, I G Petrochems, Sr.Rayala.Hypo, and Indo Borax & Ch., while Good is noted for Amines & Plast. and TGV Sraac.<BR><BR>Return Snapshot: J.G.Chemicals has the highest 1-year return at 100.68%, while Andhra Sugars has the lowest at -30.73%. Chemfab Alka.'s 1-year return is 7.63%, which is positive compared to Andhra Sugars. Additionally, the six-month returns are negative for Andhra Sugars, Chemfab Alka., and Tuticorin Alkali.

View full answer

Who are in the management team of Chemfab Alka.?

16-Jul-2025

As of March 2023, the management team of Chemfab Alka includes Chairman Suresh Krishnamurthi Rao, along with six independent directors and four non-executive directors, all contributing to the company's governance and strategic direction.

As of March 2023, the management team of Chemfab Alka includes the following individuals:<BR><BR>1. Suresh Krishnamurthi Rao - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. C S Ramesh - Non-Executive & Non-Independent Director<BR>3. R Mahendran - Non-Executive & Non-Independent Director<BR>4. Sujatha Jayarajan - Independent Director<BR>5. Drushti Desai - Independent Director<BR>6. A Janakiraman - Independent Director<BR>7. T Ramabadran - Independent Director<BR>8. Nitin S Cowlagi - Non-Executive & Non-Independent Director<BR><BR>Each member holds a significant role within the company, contributing to its governance and strategic direction.

View full answer

What does Chemfab Alka. do?

17-Jul-2025

Chemfab Alkalis Ltd manufactures caustic soda, liquid chlorine, and hydrogen gas, operating in the commodity chemicals sector. As of March 2025, it reported net sales of ₹923 Cr and a net loss of ₹92 Cr, with a market cap of ₹1,074 Cr.

Overview: <BR>Chemfab Alkalis Ltd is a manufacturer of caustic soda lye, flakes, liquid chlorine, hydrogen gas, PVCO pipes, and other products, operating in the commodity chemicals industry within the small-cap market segment.<BR><BR>History: <BR>Chemfab Alkalis Ltd was incorporated on 06 May, 2009, and was formerly known as Teamec Chlorates Limited. The company changed its name on July 21, 2017, following a Scheme of Amalgamation dated 30 March 2017. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 923 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -92 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,074 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 364.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.16% <BR>Debt Equity: 0.17 <BR>Return on Equity: 0.78% <BR>Price to Book: 2.82 <BR><BR>Contact Details: <BR>Address: Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048 <BR>Tel: 91-44-22750323/24 <BR>Email: chemfabalkalis@drraholdings.com <BR>Website: http://www.chemfabalkalis.com

View full answer

Who are the top shareholders of the Chemfab Alka.?

17-Jul-2025

The top shareholder of Chemfab Alka is Dr Rao Holdings Pte Ltd, with a 47.07% stake. V. M. Srinivasan is the largest individual shareholder at 1.81%, while individual investors hold 21.53% of the shares.

The top shareholders of Chemfab Alka include Dr Rao Holdings Pte Ltd, which holds the largest stake at 47.07%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. In terms of public shareholders, V. M. Srinivasan is the highest individual shareholder, owning 1.81%. Additionally, individual investors collectively hold 21.53% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.07% and 0.03%, respectively.

View full answer

How big is Chemfab Alka.?

24-Jul-2025

As of 24th July, Chemfab Alkalis Ltd has a market capitalization of 1,130.00 Cr and reported Net Sales of 334.37 Cr, with a Net Profit loss of 6.94 Cr in the latest four quarters. Shareholder's Funds are valued at 387.26 Cr, and Total Assets amount to 474.31 Cr.

As of 24th July, Chemfab Alkalis Ltd has a market capitalization of 1,130.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 334.37 Cr. However, it experienced a Net Profit loss of 6.94 Cr during the same period.<BR><BR>The latest annual period for the balance sheet is March 2024. Shareholder's Funds are valued at 387.26 Cr, while Total Assets amount to 474.31 Cr.

View full answer

When is the next results date for Chemfab Alka.?

28-Jul-2025

Chemfab Alka is scheduled to declare its results on July 31, 2025.

Chemfab Alka is scheduled to declare its results on 31 July 2025.

View full answer

Is Chemfab Alka. technically bullish or bearish?

04-Aug-2025

As of August 1, 2025, Chemfab Alka's trend has shifted to a moderate bearish stance, indicated by bearish MACD and Bollinger Bands, despite mixed signals from the KST.

As of 1 August 2025, the technical trend for Chemfab Alka has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly chart, bearish signals from Bollinger Bands on both weekly and monthly time frames, and a bearish moving average on the daily chart. The KST shows a mildly bullish signal on the weekly but is mildly bearish monthly, indicating mixed signals in the short term. Overall, the prevailing bearish sentiment is supported by the recent price action, with the stock down significantly year-to-date and over the past month.

View full answer

How has been the historical performance of Chemfab Alka.?

31-Oct-2025

Chemfab Alka's historical performance shows increasing net sales and total assets, but declining profitability, with a profit after tax of -INR 6.94 crore in March 2025, following a peak in March 2023. Total expenditures rose significantly, impacting operating profit and leading to negative profit before tax in 2025.

Answer:<BR>The historical performance of Chemfab Alka shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemfab Alka's net sales have seen a gradual increase from INR 204.52 crore in March 2020 to INR 334.37 crore in March 2025, with a slight dip in March 2023. Total operating income followed a similar pattern, reaching INR 334.37 crore in March 2025. However, the total expenditure has also risen significantly, from INR 149.48 crore in March 2020 to INR 290.65 crore in March 2025. This led to a decline in operating profit, which peaked at INR 115.99 crore in March 2023 but fell to INR 50.84 crore in March 2025. The profit before tax turned negative in March 2025 at INR -0.31 crore, following a positive trend in previous years. Consequently, the profit after tax also dropped to INR -6.94 crore in March 2025, contrasting with INR 64.58 crore in March 2023. The company's total assets increased from INR 296.50 crore in March 2020 to INR 498.84 crore in March 2025, while total liabilities also rose from INR 296.50 crore to INR 498.84 crore during the same period. Cash flow from operating activities improved to INR 39 crore in March 2025, although cash flow from investing activities remained negative at INR -85 crore. Overall, Chemfab Alka's financial performance reflects both growth in sales and assets, but challenges in profitability and increasing costs.

View full answer

Should I buy, sell or hold Chemfab Alkalis Ltd?

28-Jan-2026

Why is Chemfab Alkalis Ltd falling/rising?

29-Jan-2026

As of 28-Jan, Chemfab Alkalis Ltd's stock price is rising to 411.20, up 3.81%. This increase is driven by recent positive performance and higher investor participation, although long-term financial challenges remain.

As of 28-Jan, Chemfab Alkalis Ltd's stock price is rising, currently at 411.20, reflecting a change of 15.1 (3.81%) upward. This increase can be attributed to several factors. Firstly, the stock has shown a positive performance over the last week, gaining 7.64%, and has been on a consecutive gain for the last two days, with a total return of 4.86% during this period. Notably, the stock opened with a significant gap up of 18.66% today, reaching an intraday high of Rs 470.<BR><BR>Additionally, there has been rising investor participation, as indicated by a delivery volume increase of 6.54% against the 5-day average. The chemicals sector overall has also performed well, gaining 5.31%, which may contribute to the positive sentiment surrounding Chemfab Alkalis Ltd. However, it is important to note that despite these short-term gains, the company has faced significant challenges in the long term, including a decline in net sales and operating profit, which raises concerns about its overall financial health.

View full answer

Are Chemfab Alkalis Ltd latest results good or bad?

29-Jan-2026

Chemfab Alkalis Ltd's latest Q3 FY26 results are poor, showing a net loss of ₹4.45 crores and an 18.51% decline in revenue year-on-year, marking the third consecutive quarter of falling sales and significant deterioration in operating margins. Overall, the company faces serious financial challenges and a bleak outlook.

Chemfab Alkalis Ltd's latest results for Q3 FY26 indicate a challenging situation for the company. The net profit reported was a loss of ₹4.45 crores, which represents a staggering decline of 336.70% year-on-year. Revenue also fell to ₹68.14 crores, marking an 18.51% decrease compared to the same quarter last year and an 11.00% decline from the previous quarter. This decline in revenue marks the third consecutive quarter of falling sales.<BR><BR>The operating margin has significantly deteriorated, dropping to just 2.85% from 14.24% a year ago, indicating severe pricing pressures or cost inflation challenges. Additionally, the company's market capitalization has decreased by 63.86% from its 52-week high, reflecting a substantial loss in investor confidence.<BR><BR>Overall, the financial performance highlights a company in distress, with consecutive losses, collapsing margins, and liquidity concerns. The outlook appears bleak unless there is a significant turnaround in operational performance. Therefore, the latest results can be characterized as bad, with multiple red flags indicating ongoing challenges.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years

 
2

The company has declared negative results for the last 2 consecutive quarters

3

With ROCE of 1.8, it has a Expensive valuation with a 1.4 Enterprise value to Capital Employed

4

Despite the size of the company, domestic mutual funds hold only 0.25% of the company

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 543 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

39

stock-summary
Dividend Yield

0.29%

stock-summary
Debt Equity

0.29

stock-summary
Return on Equity

0.82%

stock-summary
Price to Book

1.56

Revenue and Profits:
Net Sales:
68 Cr
(Quarterly Results - Dec 2025)
Net Profit:
-4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.29%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.79%
0%
-33.79%
6 Months
-47.97%
0.17%
-47.8%
1 Year
-61.35%
0.13%
-61.22%
2 Years
0.16%
0.58%
0.74%
3 Years
56.55%
1.26%
57.81%
4 Years
115.69%
2.68%
118.37%
5 Years
197.53%
3.74%
201.27%

Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Board Meeting Intimation for Board Meeting Intimation For Approving Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Among Other Items.

22-Jan-2026 | Source : BSE

Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve Board Meeting Intimation - The meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 among other items.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

12-Jan-2026 | Source : BSE

Submission of certificate received from RTA for compliance under Reg. 74(5) of SEBI (DP) Regulation 2018.

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Company Update

06-Jan-2026 | Source : BSE

Submission of intimation that the Company has successfully commissioned the latest generation INEOS Electrolyser replacing existing 30year old 2nd generation UHDE Electrolyser and associated equipment to improve overall efficiency and optimize costs.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.44%
EBIT Growth (5y)
-6.47%
EBIT to Interest (avg)
28.40
Debt to EBITDA (avg)
0.94
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.78
Tax Ratio
49.26%
Dividend Payout Ratio
2.74%
Pledged Shares
0
Institutional Holding
0.36%
ROCE (avg)
10.65%
ROE (avg)
6.91%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
39
Price to Book Value
1.51
EV to EBIT
680.45
EV to EBITDA
21.24
EV to Capital Employed
1.40
EV to Sales
2.07
PEG Ratio
NA
Dividend Yield
0.30%
ROCE (Latest)
1.80%
ROE (Latest)
0.82%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.07%)

FIIs

Held by 2 FIIs (0.08%)

Promoter with highest holding

Dr Rao Holdings Pte Ltd (47.04%)

Highest Public shareholder

V. M. Srinivasan (1.8%)

Individual Investors Holdings

21.56%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "68.14",
          "val2": "76.56",
          "chgp": "-11.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.94",
          "val2": "5.46",
          "chgp": "-64.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.03",
          "val2": "1.94",
          "chgp": "4.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.45",
          "val2": "-2.01",
          "chgp": "-121.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.85%",
          "val2": "7.13%",
          "chgp": "-4.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.10",
          "val2": "158.43",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.76",
          "val2": "18.48",
          "chgp": "-9.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.51",
          "val2": "2.16",
          "chgp": "62.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.54",
          "val2": "0.36",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.97%",
          "val2": "11.66%",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "236.24",
          "val2": "242.05",
          "chgp": "-2.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.70",
          "val2": "30.39",
          "chgp": "-38.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.54",
          "val2": "3.36",
          "chgp": "64.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.91",
          "val2": "2.24",
          "chgp": "-274.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.92%",
          "val2": "12.56%",
          "chgp": "-4.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "334.37",
          "val2": "327.30",
          "chgp": "2.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.72",
          "val2": "53.90",
          "chgp": "-18.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.93",
          "val2": "0.94",
          "chgp": "424.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.89",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.94",
          "val2": "26.32",
          "chgp": "-126.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.08%",
          "val2": "16.47%",
          "chgp": "-3.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
68.14
76.56
-11.00%
Operating Profit (PBDIT) excl Other Income
1.94
5.46
-64.47%
Interest
2.03
1.94
4.64%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.45
-2.01
-121.39%
Operating Profit Margin (Excl OI)
2.85%
7.13%
-4.28%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
168.10
158.43
6.10%
Operating Profit (PBDIT) excl Other Income
16.76
18.48
-9.31%
Interest
3.51
2.16
62.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.54
0.36
50.00%
Operating Profit Margin (Excl OI)
9.97%
11.66%
-1.69%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
236.24
242.05
-2.40%
Operating Profit (PBDIT) excl Other Income
18.70
30.39
-38.47%
Interest
5.54
3.36
64.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.91
2.24
-274.55%
Operating Profit Margin (Excl OI)
7.92%
12.56%
-4.64%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
334.37
327.30
2.16%
Operating Profit (PBDIT) excl Other Income
43.72
53.90
-18.89%
Interest
4.93
0.94
424.47%
Exceptional Items
-9.89
0.00
Consolidate Net Profit
-6.94
26.32
-126.37%
Operating Profit Margin (Excl OI)
13.08%
16.47%
-3.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024

stock-summaryCompany CV
About Chemfab Alkalis Ltd stock-summary
stock-summary
Chemfab Alkalis Ltd
Micro Cap
Commodity Chemicals
Chemfab Alkalis Limited, formerly known as Teamec Chlorates Limited was incorporated on 06 May, 2009. The name of the Company was changed from Teamec Chlorates Limited to Chemfab Alkalis Limited on July 21, 2017, vide Revised Certi?cate of Incorporation issued by the Registrar of Companies pursuant to the Scheme of Amalgamation dated 30 March 2017. The Company is a manufacturer of caustic soda lye, ?akes, liquid chlorine, hydrogen gas, PVCO Pipes and other products.
Company Coordinates stock-summary
Company Details
Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048
stock-summary
Tel: 91-44-22750323/24
stock-summary
chemfabalkalis@drraholdings.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai